| (USD) | Dec 2020 | Y/Y change |
|---|---|---|
| Revenue | 3.74M | — |
| Operating expense | — | — |
| Net income | 189.00K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ICCC returned +62.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +60.8% |
| 1 year | +62.4% |
| 5 years | +8.0% |
| 10 years | +39.5% |
| All-time high | $12.50 (Sep 1988) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ICCC would be worth today ›No. ImmuCell Corporation has not paid a dividend in the past 12 months.
ImmuCell Corporation stock trades on NASDAQ under the ticker symbol ICCC.
ImmuCell Corporation is part of the Healthcare sector.
ImmuCell Corporation has a market cap of 89.82M USD, based on the latest quote.
ImmuCell Corporation is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
